AB
MRNA icon

Amalgamated Bank’s Moderna MRNA Stock Holding History

Amalgamated Bank’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.29M Sell
61,219
-2,592
-4% -$134K 0.03% 504
2026
Q1 		$3.24M Sell
63,811
-777
-1% -$36.3K 0.02% 597
2025
Q4 		$1.91M Sell
64,588
-1,101
-2% -$29.9K 0.01% 840
2025
Q3 		$1.7M Buy
65,689
+231
+0.4% +$6.44K 0.01% 867
2025
Q2 		$1.81M Buy
65,458
+408
+0.6% +$10.7K 0.01% 825
2025
Q1 		$1.84M Buy
65,050
+188
+0.3% +$6.67K 0.02% 807
2024
Q4 		$2.7M Sell
64,862
-812
-1% -$38.8K 0.02% 680
2024
Q3 		$4.39M Sell
65,674
-1,101
-2% -$101K 0.04% 438
2024
Q2 		$7.93M Sell
66,775
-2,110
-3% -$267K 0.07% 230
2024
Q1 		$7.34M Sell
68,885
-10,625
-13% -$1.07M 0.06% 292
2023
Q4 		$7.91M Sell
79,510
-5,519
-6% -$464K 0.06% 288
2023
Q3 		$8.78M Buy
85,029
+729
+0.9% +$81.3K 0.07% 239
2023
Q2 		$10.2M Sell
84,300
-1,519
-2% -$203K 0.08% 203
2023
Q1 		$13.2M Sell
85,819
-1,035
-1% -$171K 0.11% 148
2022
Q4 		$15.6M Sell
86,854
-122
-0.1% -$19.9K 0.14% 123
2022
Q3 		$10.3M Sell
86,976
-1,132
-1% -$172K 0.1% 167
2022
Q2 		$12.6M Sell
88,108
-3,876
-4% -$554K 0.12% 146
2022
Q1 		$15.8M Buy
91,984
+3,950
+4% +$665K 0.12% 134
2021
Q4 		$22.4M Buy
88,034
+8,744
+11% +$2.56M 0.17% 102
2021
Q3 		$30.5M Buy
79,290
+54,655
+222% +$20.2M 0.26% 65
2021
Q2 		$5.79M Buy
24,635
+10,585
+75% +$1.89M 0.05% 463
2021
Q1 		$1.84M Sell
14,050
-836
-6% -$121K 0.07% 267
2020
Q4 		$1.55M Sell
14,886
-218
-1% -$22.1K 0.06% 331
2020
Q3 		$1.07M Buy
15,104
+639
+4% +$44.6K 0.05% 417
2020
Q2 		$929K Sell
14,465
-41,451
-74% -$2.27M 0.04% 450
2020
Q1 		$1.68M Buy
55,916
+2,669
+5% +$61.4K 0.04% 425
2019
Q4 		$1.04M Buy
53,247
+3,689
+7% +$65.4K 0.02% 789
2019
Q3 		$789K Buy
+49,558
New +$732K 0.02% 842

Other funds holding MRNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $526M AUM 175.27% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Amalgamated Bank's MRNA Position: Q2 2026 in Review

Amalgamated Bank reduced its Moderna (MRNA) stake by 4.1% in Q2 2026, selling an estimated $134K and leaving 61,219 shares worth $4.29M. The position accounts for 0.03% of the portfolio, ranked #504.

Amalgamated Bank first reported a position in MRNA in Q3 2019 and has held it in 28 quarters since. The position peaked at $30.5M in Q3 2021. 434 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Amalgamated Bank held 61,219 shares of Moderna worth $4.29M as of Q2 2026.
  • Amalgamated Bank sold 2,592 Moderna shares in Q2 2026, an estimated $134K.
  • Moderna made up 0.03% of Amalgamated Bank's portfolio in Q2 2026, its #504 holding.
  • Amalgamated Bank first reported a position in Moderna in Q3 2019 and has held it in 28 quarters since.
  • Amalgamated Bank's Moderna position peaked at $30.5M in Q3 2021.
  • 434 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.